Research Article
Early Time-Dependent Dynamic Changes of TBET and GATA3 mRNA Expressions in Patients with Acute Coronary Syndrome
Table 1
Baseline characteristics of AMI and non-AMI patients.
| | | Total () | Non-AMI () | AMI () | Value |
| | Characteristic | | | | | | Age-median years (IQR) | 73 (56–81) | 74 (55–83) | 65 (56–81) | 0.477 | | Male gender—no. (%) | 20 (58) | 10 (53) | 9 (64) | 0.754 | | Time from symptom onset to blood taking for measurements of TBET & GATA3—median hours (IQR) | 4.0 (3.0–8.9) | 3.5 (2.6–5.8) | 5.3 (4.0–12.0) | 0.068 | | Past history—no. (%) | | | | | | Myocardial infarction | 5 (15) | 2 (11) | 2 (14) | 0.832 | | Cerebrovascular disease | 7 (21) | 4 (21) | 3 (21) | 0.686 | | Heart failure | 6 (18) | 4 (21) | 1 (7.0) | 0.542 | | Diabetes | 11 (33) | 4 (21) | 6 (43) | 0.335 | | Hypertension | 21 (64) | 11 (58) | 9 (64) | 0.991 | | Current smoker | 9 (27) | 5 (26) | 4 (29) | 0.801 | | Ex-smoker | 3 (24) | 0 (0.0) | 2 (14) | 0.336 | | Obesity | 6 (18) | 1 (5.0) | 4 (29) | 0.176 | | Hyperlipidemia | 6 (18) | 2 (11) | 4 (29) | 0.383 | | Atrial fibrillation | 4 (12) | 3 (16) | 1 (7) | 0.832 | | Medications—no. (%) | | | | | | Warfarin | 2 (6.0) | 2 (5.9) | 0 (0.0) | 0.607 | | Aspirin | 15 (46) | 9 (47) | 6 (17.6) | 0.923 | | Beta-blocker | 9 (33) | 4 (21) | 4 (11.8) | 0.931 | | Final diagnosis—no. (%) | | | | | | Stable angina | 8 (24) | 8 (42) | — | | | Unstable angina | 11 (33) | 11 (58) | — | | | NSTEMI | 5 (15) | — | 5 (36) | | | STEMI | 9 (27) | — | 9 (64) | | | Mortality—no. (%) | 2 (6.0) | 0 (0.0) | 2 (14) | 0.336 |
|
|
